# Saudi Arabia’s $1.3 billion biotech push following Riyadh summit — retained record

> Retained news record from news:semafor.

Canonical: https://highsignal.app/data/records/b605f95702c00aa7

[← sources](https://highsignal.app/data)


source: [news](https://highsignal.app/data/news) (news:semafor)  published 2026-09-24 09:05 ingested 2026-09-25 02:59

[original source ↗](https://www.semafor.com/article/09/23/2026/saudi-arabias-13-billion-biotech-push-following-riyadh-summit)

## retained text



```
Saudi Arabia announced $1.3 billion in biotech deals following a Riyadh summit last week, part of its push to become a global hub for the industry by 2040. They include a $130 million vaccine manufacturing plant that would be the Gulf’s largest. The deals build on Riyadh’s drive to lure global drugmakers: Eli Lilly, Johnson & Johnson, and Novo have all set up regional headquarters in the capital. Elsewhere in the Gulf, Abu Dhabi and Bahrain are also betting on AI-driven drug discovery.
Saudi Arabia is using the technology to model disease transmission and design treatments, and wants a bigger role in medical research and clinical trials while building up local talent, Bandar Alknawy, CEO of the Ministry of National Guard Health Affairs, told Semafor.
```



document fetched 2026-09-25 02:59 · canonical https://semafor.com/article/09/23/2026/saudi-arabias-13-billion-biotech-push-following-riyadh-summit